1.9(top 9%)
Impact Factor
2.2(top 9%)
extended IF
90(top 4%)
H-Index
1.4K
authors
1.4K
papers
47.5K
citations
3.7K
citing journals
26.2K
citing authors

Most Cited Articles of Pharmacogenetics and Genomics

TitleYearCitations
Doxorubicin pathways: pharmacodynamics and adverse effects2011803
Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily2005640
Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions2006489
A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs2008444
SLCO1B1 polymorphism markedly affects the pharmacokinetics of simvastatin acid2006366
Multidrug resistance polypeptide 1 (MDR1, ABCB1) variant 3435C>T affects mRNA stability2005355
Influence of CYP2B6 polymorphism on plasma and intracellular concentrations and toxicity of efavirenz and nevirapine in HIV-infected patients2005307
Functional characterization of SLCO1B1 (OATP-C) variants, SLCO1B1*5, SLCO1B1*15 and SLCO1B1*15+C1007G, by using transient expression systems of HeLa and HEK293 cells2005298
Strong association between HLA-B*5801 and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population2009287
CYP2D6 worldwide genetic variation shows high frequency of altered activity variants and no continental structure2007287
Different contributions of polymorphisms in VKORC1 and CYP2C9 to intra- and inter-population differences in maintenance dose of warfarin in Japanese, Caucasians and African-Americans2006285
Very important pharmacogene summary: ABCB1 (MDR1, P-glycoprotein)2011274
Reverse transcriptase-PCR quantification of mRNA levels from cytochrome (CYP)1, CYP2 and CYP3 families in 22 different human tissues2007264
Metformin pathways: pharmacokinetics and pharmacodynamics2012256
Mutations and polymorphisms in the bile salt export pump and the multidrug resistance protein 3 associated with drug-induced liver injury2007251
Irinotecan pharmacokinetics/pharmacodynamics and UGT1A genetic polymorphisms in Japanese: roles of UGT1A1*6 and *282007227
OCT2 polymorphisms and in-vivo renal functional consequence: studies with metformin and cimetidine2008216
Polymorphisms of the 5-HT2C receptor and leptin genes are associated with antipsychotic drug-induced weight gain in Caucasian subjects with a first-episode psychosis2005215
Genetic variability of CYP2B6 in populations of African and Asian origin: allele frequencies, novel functional variants, and possible implications for anti-HIV therapy with efavirenz2005203
Effect of genetic variation in the organic cation transporter 2 on the renal elimination of metformin2009184
The pharmacogenetics of metformin and its impact on plasma metformin steady-state levels and glycosylated hemoglobin A1c2011181
The manganese superoxide dismutase Ala16Val dimorphism modulates both mitochondrial import and mRNA stability2005179
Cytochrome P450 2C19 loss-of-function polymorphism, but not CYP3A4 IVS10 + 12G/A and P2Y12 T744C polymorphisms, is associated with response variability to dual antiplatelet treatment in high-risk vascular patients2007173
Valproic acid pathway: pharmacokinetics and pharmacodynamics2013172
Cytochrome P450 2C9-CYP2C92010168